July 2020

ENDOCRINOLOGY

NEW ROLE FOR RNA SPLICING IN INSULIN REGULATION

Featuring: Joseph Bass, MD, PhD

​​The gene transcription machinery that controls circadian rhythm also regulates insulin release in the pancreas, according to a Northwestern Medicine study published in the journal Genes and Development.

Mouse models with a mutated clock gene also failed to release insulin from beta cells in the pancreas, due to aberrant RNA splicing. This is the first time scientists have identified RNA regulation as a mechanism by which the internal body clock affects systems beyond the sleep-wake cycle, according to Joseph Bass, MD, PhD, the Charles F. Kettering Professor of Medicine in the Division of Endocrinology, director of the Center for Diabetes and Metabolism and senior author of the study.

“This should raise interest in other areas of the body, for people to search for RNA shuffling as an explanation for how timing regulates biologic systems,” said Bass, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Mammalian circadian rhythm is regulated by a complex gene transcription feedback loop. Specialized cells in the brain detect light or darkness, and through gene transcription, set a day and night cycle that in turn influences a variety of functions throughout the entire body.

In the early days of clock transcription science, Bass discovered that turning off a gene crucial for clock transcription caused mice to develop diabetes due to lack of insulin production. However, the precise connection between the clock gene and insulin regulation was unclear and analyzing the impact of clock gene deletion through RNA sequencing was inconclusive, Bass said.

In the current study, Bass and his collaborators took a second look. Specifically, they focused on RNA splicing, a re-shuffling of RNA that occurs in gaps between coding regions. In normal RNA analysis, RNA splicing is unmeasured and invisible, but the investigators used an alternative sequencing approach in order to consider the effect of the splicing.

Comparing normal mice to mice without the clock gene, the investigators found significant changes. Certain proteins expressed during specific time windows during the daytime increased in activity due to changes in RNA splicing. Mice without the clock gene — and therefore, these splicing changes — had dramatically lower levels of insulin released during the time of day when animals eat, resulting in diabetes and obesity.
“The protein is the same, but splicing generates a coding sequence that’s included with the protein, generating a different functional form of the protein,” Bass said.
The investigators took this one step further, generating pancreatic islet cells with the intact clock protein and the specific aberrant splicing changes, finding it reproduced defects in insulin release.

“All these approaches pointed to one thing: splicing is a way that the pancreas tells when it is time to make insulin and a hallmark of diabetes is a failure in this process,” Bass said.
While Bass hopes that other scientists will examine the role of splicing in other organs and systems, beta cell failure is also experienced by patients with late-stage diabetes, so these findings could inform treatments down the line.

“One possibility may be that restoring splicing could enhance beta-cell function,” Bass said. “It’s a long-term question, but it’s a potential therapeutic strategy.”

This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants R01DK090625, DK007169, R01DK100814 and 1R01DK113011-01A1; National Institute on Aging (NIA) grant P01AG011412; the Chicago Biomedical Consortium grant S-007; JDRF grants 17-2013-511, 1-INO-2014-178-A-V and 1-INO-2015-23-A-V; and the University of Chicago Diabetes Research and Training Center grant P60DK020595; National Research Service Award (NRSA) grant F32HL143978; National Heart, Lung, and Blood Institute (NHLBI) T32 grant HL007909; National Research Service Award (NRSA) grant F30DK116481; Manpei Suzuki Diabetes Foundation Fellowship; a National Science Foundation fellowship; a studentship from the Li Ka Shing Foundation; NIH grants R01HL061322 and HG004659; and a Foundation Grant from the Canadian Institutes of Health Research.
​
This article was originally published in the Feinberg School of Medicine News Center on July 2, 2020 . 
Joseph Bass, MD, PhD, the Charles F. Kettering Professor of Medicine, director of the Center for Diabetes and Metabolism and chief of Endocrinology in the Department of Medicine, was senior author of the study published in Genes and Development. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like